Regulatory News
Tuesday, March 22, 2016
BRIEF-FDA grants fast track designation for Medicinova's drug for progressive multiple sclerosis
* FDA grants fast track designation for Medicinova's MN-166
(ibudilast) for progressive multiple sclerosis
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment